.
- MedITEX IVF facilitates organisation, documentation and quality assurance in the field of reproductive medicine
- MedITEX from 28 June to 1 July 2009 at the ESHRE exhibition in Amsterdam (Stand 87/88)
The IT consulting company CRITEX, which specialises in medical solutions, is set to present its new software for in vitro fertilisation, MedITEX IVF, at the 25th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) to be held in Amsterdam from 28 June to 1 July. The software solution is the only officially approved program in Germany for the documentation and quality assurance of ART and non-ART treatments, as well as for the informing of patients and the further processing of data for scientific analysis. MedITEX IVF successfully stands the test of over 200,000 documented treatments. On ESHRE 2009 Stand, visitors can pick up a USB stick with demo versions of the software.
MedITEX IVF has been developed by IT specialists and medical experts specifically for clinics, medical centres and practices specialising in infertility. The software can be specially adapted to meet the particular technical and organisational requirements of a given practice, and its user-friendly interface enables the intelligent organisation of processes and the transparent documentation of information and confidential data. Thanks to the software's sophisticated visual design, each individual egg cell obtained can be displayed graphically with regard to the development stage, type of treatment and planned action, as can the entire treatment cycle. A sophisticated security model protects the software from unauthorised access and data loss.
MedITEX IVF incorporates state-of-the-art technology, such as bar codes, RFID, DICOM, an online patient information portal and interfaces to medical equipment and software, as well as numerous possibilities to extend the solution. In addition, the software takes into account all the latest developments and requirements in the field of reproductive medicine; these include new EU directives governing the individual identification and tracking of egg cells and sperm samples, professional specifications relating to verification and data management, the growing importance of quality assurance, as well as the introduction of new forms of treatment or legal policies.
- MedITEX IVF facilitates organisation, documentation and quality assurance in the field of reproductive medicine
- MedITEX from 28 June to 1 July 2009 at the ESHRE exhibition in Amsterdam (Stand 87/88)
The IT consulting company CRITEX, which specialises in medical solutions, is set to present its new software for in vitro fertilisation, MedITEX IVF, at the 25th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) to be held in Amsterdam from 28 June to 1 July. The software solution is the only officially approved program in Germany for the documentation and quality assurance of ART and non-ART treatments, as well as for the informing of patients and the further processing of data for scientific analysis. MedITEX IVF successfully stands the test of over 200,000 documented treatments. On ESHRE 2009 Stand, visitors can pick up a USB stick with demo versions of the software.
MedITEX IVF has been developed by IT specialists and medical experts specifically for clinics, medical centres and practices specialising in infertility. The software can be specially adapted to meet the particular technical and organisational requirements of a given practice, and its user-friendly interface enables the intelligent organisation of processes and the transparent documentation of information and confidential data. Thanks to the software's sophisticated visual design, each individual egg cell obtained can be displayed graphically with regard to the development stage, type of treatment and planned action, as can the entire treatment cycle. A sophisticated security model protects the software from unauthorised access and data loss.
MedITEX IVF incorporates state-of-the-art technology, such as bar codes, RFID, DICOM, an online patient information portal and interfaces to medical equipment and software, as well as numerous possibilities to extend the solution. In addition, the software takes into account all the latest developments and requirements in the field of reproductive medicine; these include new EU directives governing the individual identification and tracking of egg cells and sperm samples, professional specifications relating to verification and data management, the growing importance of quality assurance, as well as the introduction of new forms of treatment or legal policies.
